Press Release Archive - Corporate News

Corporate News

07.09.2012
Howard Solomon Sends Letter to Carl Icahn
07.02.2012
Forest Laboratories Issues Response to Carl Icahn Letter
07.02.2012
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2013 First Quarter Earnings
06.11.2012
Forest Laboratories, Inc. Revises Fiscal Year 2013 Earnings Guidance Primarily Due to Evolving Conditions in the Lexapro / escitalopram Market
06.01.2012
Forest Laboratories and Nabriva Therapeutics Sign Agreement
05.30.2012
Forest Laboratories Comments on Icahn 13D Filing
05.18.2012
Forest and Almirall to Present Aclidinium Bromide Clinical Data at the American Thoracic Society (ATS) International Conference
05.14.2012
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012
05.04.2012
Forest Laboratories, Inc. to Present Cariprazine and Levomilnacipran Results from Phase 3 Trials at American Psychiatric Association (APA) Annual Meeting
04.26.2012
Forest Laboratories, Inc. and Pierre Fabre Medicament Announce Third Positive Phase III Study for Levomilnacipran in Patients with Major Depressive Disorder